The members of Chartwell Pharmaceuticals’ LLC. leadership team each have over 20 years of experience in the generic pharmaceutical industry. With a rich pool of combined experience in manufacturing and distribution, our leadership continues to be hands-on, from the development process to manufacturing and commercial operations. That’s just one of the many ways we’re improving our products and portfolio to meet the needs of today’s market.

Jack Goldenberg

Managing Member

Lance Kann

Senior Executive Vice President
Corporate Development and Strategy

Lance brings 40 years of global experience in the pharmaceutical industry, having worked for top tier firms including Cipla, Teva, IVAX, Mylan, and Wyeth/Lederle (now Pfizer), and is on the Advisory Board of Brother’s Brother Foundation.

His expertise includes corporate development, business planning, global operations, API and formulations, end-to-end supply chain, project and product life-cycle management and information technology. He is recognized for bringing innovative and transformative, pragmatic approaches to address business challenges and customer needs.

Lance holds a BS in Biochemistry/Chemistry from Rutgers University and an MBA in Industrial Management from Fairleigh Dickinson University.

Mark Blitman

Executive Vice President
Government Sales

Mark has over 45 years of experience in pharmaceutical government affairs, sales and marketing experience with McNeil Pharma, Goldline Laboratories, IVAX, Watson, Actavis and Teva. Mark has also worked on the Health Industry Federal Advisory Council subcommittees and the VA subcommittee of Association of Military Surgeons of the United States.

Mark earned his B.A. degree from the University of Missouri and attended Washburn University School of Law. While at IVAX, Mark convinced upper level management to support our country in time of need and devote 30% of their total manufacturing capacity to producing Doxycycline and Ciprofloxacin for the newly created National Strategic Stockpile.

Kerry Collias

Executive Vice President
Sales and Marketing

Kerry has nearly 30 years’ experience in generic sales, marketing and business development. She served in multiple sales and marketing positions at Goldline, Zenith Goldline and IVAX, including developing and managing the inside and field sales teams promoting OTC and prescription products to retail, institutional and government accounts. She was also responsible for OTC, vitamin and prescription product management and forecasting, launching numerous blockbuster and first-to-file generics.

Most recently, she was Director of Business Development for Harris Pharmaceutical, responsible for business development and manufacturing partner alliances. She also led commercial operations, including national accounts, contracts and pricing, distribution and customer service.

Kerry has a BBA in Marketing from Marshall University.

Monique Weitz

Executive Vice President
Regulatory Affairs

Monique possesses 25 years of experience in the pharmaceutical industry. Prior to joining Chartwell, she worked for Cipla North America as Head of Regulatory Affairs and also at Actavis as a Senior Director, Regulatory Affairs. Previously, she held management positions in project management at Elan and Abrika. Her professional work experience started at Sano (Elan) where she served as a chemist, Quality Control supervisor and Quality Assurance Manager.

Monique earned her BS in Biology, BA in Chemistry, and MBA at Florida Atlantic University in Boca Raton, FL. She holds a Regulatory Affairs Certificate (RAC) and a Project Management Profession (PMP) Certificate.

Vinia Jeudy

Vice President
Quality Assurance

Vinia possesses nearly 20 years of experience with Quality, having worked in top global firms such as Pfizer, Aptar and Intercos. She has an extensive background in current FDA regulations and is skilled in ISO and cGMP regulated environments. Her expertise is in preparation for FDA site inspections, audits, risk management, lot disposition and quality systems. She has worked in various industries such as pharmaceuticals, medical devices, nutritional products and cosmetics.

As Vice President of Quality Assurance, she is responsible for overseeing all of Chartwell quality operations in support of commercial activities originating from manufacturing, laboratories and third-party facilities.

Vinia received a BS in Biology with a concentration in Biotechnology from Fairleigh Dickinson University. She holds multiple certifications including Hazard Analysis and Critical Control Points /Risk Management, Bloodborne Pathogen Protection, Drug Development and Pharmaceutical Quality Assurance.